Nathália Pereira

Ms. Nathália Pereira

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2021 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
TFThiago Cezar Fujita
Thiago Cezar Fujita
NPNathália Pereira
Nathália Pereira
MAMarla Amarante
Marla Amarante
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe


23 May 2023 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
MBMayara Bocchi
Mayara Bocchi
NPNathália Pereira
Nathália Pereira
KOKaren Brajão de Oliveira
Karen Brajão de Oliveira
MAMarla Amarante
Marla Amarante

NPNathália Pereira
Nathália Pereira
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
BBBruna Karina Banin-Hirata
Bruna Karina Banin-Hirata
GFGlaura Scantamburlo Fernandes
Glaura Scantamburlo Fernandes
MSMaria José Sparça Salles
Maria José Sparça Salles
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe
Background: Breast cancer (BC) is a complex disease in which susceptibility and clinical course depend on multiple factors. Evidence suggests that a mouse mammary tumor virus (MMTV)-homolog may be present in human BCs; however, little is known about its clinical implications. Methods: MMTV-like env nucleotide-sequence was searched in tumor and tumor-adjacent tissues from 217 Brazilian BC patients through nested-PCR and confirmed through PCR-sequencing. Blood samples were also tested for patients with MMTV-like env gene-positive tumors. Correlations with clinicopathological parameters were evaluated. Results: MMTV-like env sequence was detected in tumor and tumor-adjacent tissue samples from 41/217 and 30/196 patients, respectively. In blood, MMTV-like was detected in 17/32 patients. In Luminal-B tumors, MMTV-like in tumor tissue was negatively correlated with tumor size and disease stage, whereas in HER2 tumors it anti-correlated with lymph node metastasis (LNM) and disease stage. Considering blood, MMTV-like env gene positivity negatively correlated with age in general BC, while in Luminal-A tumors it positively correlated with Ki67 but negatively correlated with age and LNM. The associations with decreased LNM frequency were independent of other prognostic factors. Conclusion: MMTV-like env positivity is associated with better prognostic parameters in BC subtypes, which might be explainable by its anti-metastatic potential and by putative activation of immune milieu.

13 April 2020 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
Glauco Akelinghton Freire VItielloGlauco Akelinghton Freire VItiello
Glauco Akelinghton Freire VItiello
NPNathália Pereira
Nathália Pereira
MAMarla Amarante
Marla Amarante
BBBruna Karina Banin-Hirata
Bruna Karina Banin-Hirata
CCClodoaldo Zago Campos
Clodoaldo Zago Campos
MWMaria Angelica Ehara Watanabe
Maria Angelica Ehara Watanabe

4 August 2025 in Immuno
Verified
Journal Article
Open access
PDF file
MBMayara Bocchi
Mayara Bocchi
EFEduardo VIGNOTO FERNANDES
Eduardo VIGNOTO FERNANDES
NPNathália Pereira
Nathália Pereira
MAMarla Amarante
Marla Amarante
Human colorectal cancer (CRC) encompasses tumors affecting a segment of the large intestine (colon) and rectum. It is the third most commonly diagnosed malignancy and the second leading cause of cancer deaths worldwide. It is a multifactorial disease, whose carcinogenesis process involves genetic and epigenetic alterations in oncogenes and tumor suppressor genes, including genes related to DNA repair. The pathogenic mechanisms are described based on the pathways of chromosomal instability, microsatellite instability, and CpG island methylator phenotype. When detected early, CRC is potentially curable, and its treatment is based on the pathological characteristics of the tumor and factors related to the patient, as well as on drug efficacy and toxicity studies. Therefore, the aim of this study was to review the pathogenesis and molecular subtypes of CRC and to describe the main targets of disease-directed therapy used in patients refractory to current treatments.